The role of cancer stem cells in colorectal cancer: from the basics to novel clinical trials

C Hervieu, N Christou, S Battu, M Mathonnet - Cancers, 2021 - mdpi.com
Simple Summary Cancer stem cells (CSCs) fuel tumor growth, metastasis and resistance to
therapy in colorectal cancer (CRC). These cells therefore represent a promising target for …

[HTML][HTML] Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges

AG Vaiopoulos, KC Athanasoula… - Biochimica et Biophysica …, 2014 - Elsevier
Colorectal cancer, a leading cause of mortality worldwide, is a multistep disorder that results
from the alteration of genetic and epigenetic mechanisms under contextual influence …

Self-renewal as a therapeutic target in human colorectal cancer

A Kreso, P Van Galen, NM Pedley… - Nature medicine, 2014 - nature.com
Tumor recurrence following treatment remains a major clinical challenge. Evidence from
xenograft models and human trials indicates selective enrichment of cancer-initiating cells …

Oncogenicity of the developmental transcription factor Sox9

A Matheu, M Collado, C Wise, L Manterola, L Cekaite… - Cancer research, 2012 - AACR
SOX9 [sex-determining region Y (SRY)-box 9 protein], a high mobility group box
transcription factor, plays critical roles during embryogenesis and its activity is required for …

Reversing tumor stemness via orally targeted nanoparticles achieves efficient colon cancer treatment

J Xu, Y Zhang, J Xu, M Wang, G Liu, J Wang, X Zhao… - Biomaterials, 2019 - Elsevier
The acquisition of stemness in colorectal cancer (CRC) attributed to the recurrence and
metastasis in CRC treatment. Therefore, targeting the stemness of CRC forms a basis for the …

Cancer stem cell self-renewal as a therapeutic target in human oral cancer

J Hu, S Mirshahidi, A Simental, SC Lee… - Oncogene, 2019 - nature.com
Tumor recurrence following treatment remains a major clinical challenge in oral cavity
cancer. Cancer stem cells (CSCs) have been isolated from human oral cancers and been …

Multifaceted interpretation of colon cancer stem cells

Y Hatano, S Fukuda, K Hisamatsu, A Hirata… - International journal of …, 2017 - mdpi.com
Colon cancer is one of the leading causes of cancer-related deaths worldwide, despite
recent advances in clinical oncology. Accumulating evidence sheds light on the existence of …

Personalized medicine—current and emerging predictive and prognostic biomarkers in colorectal cancer

C Koulis, R Yap, R Engel, T Jardé, S Wilkins, G Solon… - Cancers, 2020 - mdpi.com
Colorectal cancer (CRC) is the third most common cancer diagnosed worldwide and is
heterogeneous both morphologically and molecularly. In an era of personalized medicine …

Prognostic value of polycomb proteins EZH2, BMI1 and SUZ12 and histone modification H3K27me3 in colorectal cancer

A Benard, IJ Goossens-Beumer, AQ van Hoesel… - PloS one, 2014 - journals.plos.org
Numerous changes in epigenetic mechanisms have been described in various types of
tumors. In search for new biomarkers, we investigated the expression of Polycomb-group …

The role of colorectal cancer stem cells in metastatic disease and therapeutic response

EC Anderson, C Hessman, TG Levin, MM Monroe… - Cancers, 2011 - mdpi.com
Colorectal cancer is the third-leading cause of cancer related mortality in the United States.
The intricate molecular mechanisms involved in the regenerative process of the normal …